⌕
Argen X · ARGX · Nasdaq
Tenet 88 · Strong
Compare
$960.04−2.17%At closeTenet 88 · Strong
$960.04−21.29 (−2.17%)
At close: Nov 13, 2026, 4:00 PM ET· Nasdaq · USD

Argen X (ARGX) Stock

Argen X (ARGX) closed at $960.04 on Nov 13, 2026; its Tenet Score is 88 of 100 against 409 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

17 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$960.04
Nov 13, 2026
Market cap
$59.4Bunverified basis
share basis not confirmed
P/E
46.0×
price ÷ earnings
52-week range
661.85 – 1072.75
low → high
Tenet Score
88/100
Strong · 409 Healthcare peers

Industry: Drugs · see every company filed here →

Argen X SE scores 88/100. Strong. Strongest on growth and quality, trading at 46× earnings versus 409 Healthcare peers. Insufficient inputs: Tenet 88 is built from 3 of 4 pillars, from 40% of its inputs. The pillars showing a dash had no data.

Tenet Score · vs sector

n=409
88/ 100
Strong
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
—
Quality
88
Health
76
Growth
99

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
Value omitted — no data yet.
Value—QualityBHealthBGrowthA+MomentumD
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
52.3×
price to book value
P/S
13.8×
price to sales
ROE
377%
return on equity
Operating margin
26.2%
before interest and tax
Net margin
30.0%
of revenue kept
Current ratio
5.23
current assets to liabilities
Net debt / EBITDA
−3.0×
leverage, net of cash
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

Market cap: share price × the latest quarter's diluted weighted-average share count (vendor).

The whole report, at a glance · every card is a live peek, click any to open the section

About Argen X SE

argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the t…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=409) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 75 US ETFs · top wrappers by weightSee all ETFs holding ARGX →

What sector and industry is Argen X in?

Argen X is in the Healthcare sector and the Drugs industry.

What is Argen X's Tenet Score?

Argen X's Tenet Score is 88 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.